American Cytogenetics named M. L. Back as...
- Share via
American Cytogenetics named M. L. Back as president and chief executive to succeed Al Manzano, who resigned.
The North Hollywood-based company, through its Cancer Screen Services unit, operates medical testing labs and has struggled in recent years. As it announced Back’s promotion, American Cytogenetics also reported a $935,018 loss for its fiscal year that ended Jan. 31.
Back, the company’s third president in the past year, previously was vice president, treasurer and chief financial officer of the company. She earlier held various management posts with Cooper Cos.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
